Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company’s cutting-edge platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
View Top Employees from Vividion Therapeutics, Inc.Website | http://www.vividion.com |
Revenue | $34.4 million |
Funding | $290.7 million |
Employees | 224 (187 on RocketReach) |
Founded | 2017 |
Address | 5820 Nancy Ridge Dr, San Diego, California 92121, US |
Phone | (858) 345-4690 |
Technologies |
JavaScript,
HTML,
Twitter
+29 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare, Science and Engineering, Health Care, Therapeutics |
Web Rank | 7 Million |
Keywords | Small Molecule Drug Discovery, Oncology, Innovative Drug Development, Precision Oncology, Immuno-Oncology, Chemical |
Competitors | Atreca, Inc., Bolt Biotherapeutics, Inc., IDEAYA Biosciences, ORIC Pharmaceuticals Inc., Zentalis Pharmaceuticals |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5413 Companies, NAICS Code 54138 Companies |
Looking for a particular Vividion Therapeutics, Inc. employee's phone or email?
The Vividion Therapeutics, Inc. annual revenue was $34.4 million in 2024.
Jeff Hatfield is the CEO of Vividion Therapeutics, Inc..
187 people are employed at Vividion Therapeutics, Inc..
Vividion Therapeutics, Inc. is based in San Diego, California.
The NAICS codes for Vividion Therapeutics, Inc. are [54, 541, 5413, 54138].
The SIC codes for Vividion Therapeutics, Inc. are [87, 873].